Informations:
Erreur:
ID
34587
Description
Efficacy and Safety of the Fixed Dose Combination of Glimepiride+Metformin in Type 2 Diabetic Patients Inadequately Controlled; ODM derived from: https://clinicaltrials.gov/show/NCT01699932
Lien
https://clinicaltrials.gov/show/NCT01699932
Mots-clés
Versions (1)
- 19/01/2019 19/01/2019 -
Détendeur de droits
see on clinicaltrials.gov
Téléchargé le
19 janvier 2019
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Type 2 Diabetes Mellitus NCT01699932
Eligibility Type 2 Diabetes Mellitus NCT01699932
- StudyEvent: Eligibility
Similar models
Eligibility Type 2 Diabetes Mellitus NCT01699932
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
ID.1
Item
patients with type 2 diabetes mellitus inadequately controlled despite a treatment with sulfonylurea (su) alone or metformin alone or a free combination of su and metformin prior to the study entry.
boolean
ID.2
Item
signed informed consent, obtained prior any study procedure
boolean
ID.3
Item
age < legal age of adulthood
boolean
ID.4
Item
hba1c < 7% or ≥ 11%
boolean
ID.5
Item
bmi > 35 kg/m2
boolean
ID.6
Item
treatment with a stable dose of maximally tolerated su alone or metformin alone or the free combination of su and metformin for less than 12 weeks prior to the screening visit.
boolean
ID.7
Item
patients who received any anti-diabetic drug other than su or metformin within 12 weeks prior to the screening visit.
boolean
ID.8
Item
diabetes other than type 2 diabetes (e.g. type 1 diabetes, diabetes secondary to pancreatic disorders, drug or chemical agent intake…)
boolean
ID.9
Item
the above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
boolean